Table 1

CGG size, per cent of methylation measured by Southern blot analysis and clinical measures for the 17 males with an expanded CGG repeat allele

Case	CGG*	Age	Per cent methylation	IQ	Anxiety	ADHD	Perseveration	Tantrums	ASD/PDDNOS
1	107	69	5	123	√	–	–	–	–
2	121	19	9	91	√	√	√	√	–
3	138	3	9	97	–	–	–	–	–
4	155	14	6	51	√	√	√	√	√
5	150, 180	8	<2	116	√	√	√	√	–
6	157, 180	8	3	124	√	√	√	√	–
7	163	8	7	95	√	√	√	√	√
8	162	21	19	68	√	√	–	–	–
9	160–190	22	2	97	√	√	√	√	√
10	170	18	7	54	√	√	√	√	√
11	177	10	48	63	√	√	√	√	√
12	187	7	11	62	√	√	√	√	√
13	188	9	21	60	√	√	√	√	–
14	192	7	25	111	–	√	√	–	√
15	192	4	35	55	√	√	√	√	√
16	220	21	79	NA	NA	NA	NA	NA	NA
17	250	9	84	55	√	√	√	√	√

*All 17 cases show series of peaks by CE indicating the presence of multiple CGG repeat alleles. The CGG size reported in the table is correspondent to the major peak(s). Both the CGG and per cent of methylation reported in the table were measured in peripheral blood.
ASD, autism spectrum disorders.